DigitalOcean R&D increased by 10.3% to $48.83M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.3%, from $39.59M to $48.83M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 8.7% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $27.12M | $29.93M | $36.23M | $37.24M | $36.96M | $30.24M | $39.45M | $37.51M | $37.70M | $31.73M | $29.98M | $32.93M | $32.98M | $36.28M | $40.31M | $39.59M | $39.64M | $38.12M | $44.26M | $48.83M |
| QoQ Change | — | +10.3% | +21.1% | +2.8% | -0.8% | -18.2% | +30.4% | -4.9% | +0.5% | -15.8% | -5.5% | +9.8% | +0.2% | +10.0% | +11.1% | -1.8% | +0.1% | -3.8% | +16.1% | +10.3% |
| YoY Change | — | — | — | — | +36.3% | +1.1% | +8.9% | +0.7% | +2.0% | +4.9% | -24.0% | -12.2% | -12.5% | +14.3% | +34.5% | +20.2% | +20.2% | +5.1% | +9.8% | +23.3% |